ClinicalTrials.gg
Sign In

Phobic Disorders clinical trials

The registry lists 84 studies for Phobic Disorders across more than 10 countries. 15 are recruiting or about to start. 41 of them are mainly about Phobic Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 8 narrower conditions too, such as Phobia, Social: 861 studies, 186 open.

Get an email when these change. Save the Phobic Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
51
Status unknown
11
Recruiting
9
Enrolling by invitation
4
Terminated
3
Withdrawn
3

Phase

Phase 2
16
Phase 3
8
Phase 1
4
Phase 4
2

Where

United States
45
Germany
5
United Kingdom
3
Switzerland
3
France
3
Canada
3

Who runs them

University of California, Los Angeles (4) · Bradley Hospital (3) · University of South Florida (2) · University of Texas at Austin (2) · Virginia Polytechnic Institute and State University (2) · VistaGen Therapeutics, Inc. (2) · VU University of Amsterdam (2) · University of Central Florida (2)

What is being tested here

Drugs under test in Phobic Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cycloserine013
Fasedienol012
Hydrocortisone002
JNJ-42165279001
Propofol001
Thiopental001
Aticaprant001
Paroxetine001
Sertraline011
Fluoxetine011

Drug classes tested here SSRIs 4

Coming up

1phase 3 study under way
6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Who these studies take

Of the 9 Phobic Disorders studies recruiting now, 2 (22%) set no upper age limit and 7 (78%) stop at 75 or younger. 5 (56%) take children under 18. 1 (11%) are for women only and 0 (0%) for men only; 2 (22%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
104 (44%)4 (44%)
187 (78%)6 (67%)
305 (56%)4 (44%)
405 (56%)4 (44%)
505 (56%)4 (44%)
654 (44%)3 (33%)
752 (22%)1 (11%)
852 (22%)1 (11%)

Across all 84 studies, recruiting or not: 71% stop at 75 or younger and 69% at 65; 35% take children; 2% are for women only and 0% for men only; 35% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Phobic Disorders studies take

Of 28 interventional studies with no phase under Phobic Disorders, half reached primary completion within 31 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase31 mo9–44 · 28 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 84. Browse all 84 → or search them.